Cash flow

Our support aims to help your company to gain quick wins from short-term optimizations and outline the future direction for sustainable business in periods of distress. We can also support your company to implement the initiatives outlined in the action plan derived based on the analysis performed.

Events are moving very fast. The COVID-19 pandemic is the main topic on the news. Already we are hearing news of profitable and well managed companies needing to take drastic action to maintain headroom

Understanding the needs of companies and establishing an immediate action plan to simplify customs operations and combat the economic consequences of the COVID-19 pandemic represent a priority. We can provide you with the right solutions for your business operations and business model.

Considering the significant financial impact of the COVID-19 pandemic on most companies, identifying opportunities to improve cash flow and mitigate the economic impact of this disruptive situation becomes essential. One of the VAT cash-saving opportunities relates to bad debts.

Having a business diagnostic analysis performed as early as possible will assist both banks and borrowers to apply best solutions in order to align the interests regarding debt repayment from a financial, legal and risk perspective.

With businesses disrupted as a result of COVID-19, more pressure will be put on companies’ ability to maintain adequate liquidity. Therefore, companies will need to work on different versions of plans and to analyze key business drivers in order to identify the most plausible alternate future.

Straining businesses’ cash and working capital is one of the effects of the collapsing demand and the supply chain shutdowns. Companies are encouraged to seek to improve cash flow by optimizing working capital and identifying “quick-win” self-help measures for optimal results.

Due to the unprecedented business disruption and capital markets declines brought on by macro triggering events such as COVID-19, clients are asking advisors for perspectives around impairment testing due market price decline and impacts to business and supply chains etc.